Blood-Derived injection may ease jaw pain better than steroids
NCT ID NCT07691684
First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study tested whether an injection of platelet-rich plasma (PRP) made from a patient's own blood can reduce pain and clicking in the jaw joint (TMJ) and improve mouth opening. Thirty adults with a slipped jaw disc were randomly assigned to receive PRP, a steroid with anesthetic, or a saltwater placebo. After one week, both PRP and the steroid reduced pain and clicking more than placebo, and PRP also improved how wide patients could open their mouth.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Platelet-Rich Plasma (PRP) and Dexamethasone with Local Anaesthetic
- What this could lead to
- If PRP proves effective, it could offer a longer-lasting, natural treatment for TMJ disorders without the side effects of steroids.
- What could go wrong
- This is a small, early-stage trial with only 30 participants and short follow-up. Results may not apply to all TMJ patients, and PRP's benefits over time are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Dec 2025
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Inclusion Criteria: * Skeletally mature patients aged 18 years or older * Symptomatic TMJ internal derangement in the form of disc displacement with reduction (DDwR), diagnosed using DC/TMD Axis I clinical criteria * TMJ arthralgia confirmed by pain reproduced on palpation or provoked by jaw movement * Clicking sound detectable on palpation or auscultation during opening and closing movements * Elimination or marked reduction of the click on mouth opening from a protruded position Exclusion Criteria: * Intra-articular injection within the previous six months * Systemic inflammatory arthropathy * Coagulopathy * Active local infection * Low platelet count * Ongoing antiplatelet or anticoagulant therapy * Pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Temporomandibular joint disorders are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
College of Dentistry, University of Anbar
Ramadi, Al Najaf, 54001, Iraq
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood concentrate injection may offer new hope for jaw joint pain
- Can Hands-On therapy beat home exercises for jaw pain?
- Can a single injection ease jaw joint pain?
- Can a single Anti-Inflammatory injection boost jaw joint relief?
- Can a simple joint wash beat botox for jaw pain?
- Could a Blood-Derived injection ease jaw pain without surgery?